Barbara Schrörs
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 12
- Immunotherapy and Immune Responses 12
- Oncology 11
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 6
- Co-authors
- Martin Löwer (16 shared papers)Uğur Şahin (16 shared papers)Özlem Türeci (6 shared papers)Mathias Vormehr (5 shared papers)Arbel D. Tadmor (3 shared papers)Sebastian Boegel (3 shared papers)Franziska Lang (7 shared papers)Mustafa Diken (5 shared papers)
- Journals
- Nature Reviews Drug Discovery (2 papers)OncoImmunology (2 papers)Bioinformatics (1 paper)Oncotarget (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- GermanyUnited KingdomNorway
In The Last Decade
Barbara Schrörs
22 papers receiving 1.8k citations
Barbara Schrörs's Hit Papers
Peers
Comparison fields: 5 of 77
- Immunology 1.2k
- Oncology 937
- Molecular Biology 745
- Cancer Research 124
- Radiology, Nuclear Medicine and Imaging 156
Countries citing papers authored by Barbara Schrörs
This map shows the geographic impact of Barbara Schrörs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Schrörs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Schrörs more than expected).
Fields of papers citing papers by Barbara Schrörs
This network shows the impact of papers produced by Barbara Schrörs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Schrörs. The network helps show where Barbara Schrörs may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Schrörs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutant MHC class II epitopes drive therapeutic immune responses to cancer Hit paper breakdown → | 2015 | 947 |
| 2 | Identification of neoantigens for individualized therapeutic cancer vaccines Hit paper breakdown → | 2022 | 352 |
| 3 | 2020 | 148 | |
| 4 | 2016 | 59 | |
| 5 | 2020 | 45 | |
| 6 | 2020 | 42 | |
| 7 | 2022 | 40 | |
| 8 | 2018 | 38 | |
| 9 | 2015 | 35 | |
| 10 | 2017 | 26 | |
| 11 | 2021 | 26 | |
| 12 | 2018 | 25 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2023 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Barbara Schrörs
Barbara Schrörs is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), vaccines and immunoinformatics approaches (8 papers), CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Genomics and Diagnostics (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Immunology (1.2k citations), Oncology (937 citations), Molecular Biology (745 citations), Cancer Research (124 citations) and Radiology, Nuclear Medicine and Imaging (156 citations). Barbara Schrörs has collaborated with scholars based in Germany, United Kingdom and Norway. Frequent co-authors include Martin Löwer, Uğur Şahin, Özlem Türeci, Mathias Vormehr, Arbel D. Tadmor, Sebastian Boegel, Franziska Lang, Mustafa Diken, Sebastian Kreiter and Fulvia Vascotto. Their work appears in journals such as Nature Reviews Drug Discovery, OncoImmunology, Bioinformatics, Oncotarget and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.